Payables and Accruals |
12 Months Ended | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||
| Payables and Accruals [Abstract] | ||||||||||||||||||||||
| Accounts Payable and Accrued Liabilities Disclosure | Accounts Payable We have an agreement with a third party that allows our participating suppliers to finance payment obligations from us with a designated third-party financial institution who act as our paying agent. We have generally extended our payment terms with suppliers to 90 days. A participating supplier may request the participating financial institution to finance one or more of our payment obligations to such supplier prior to the scheduled due date thereof at a discounted price. We are not required to provide collateral to the financial institution. Our obligations to participating suppliers, including amounts due and scheduled payment dates, are not impacted by the suppliers’ decisions to finance amounts due under these financing arrangements. Our outstanding payment obligations under this agreement was $280 million as of December 31, 2025, and $317 million as of December 31, 2024, and are included in “Accounts payable” on the Consolidated Balance Sheets. The following table presents a rollforward of our supplier finance program obligations:
|
|||||||||||||||||||||